Raised serum CEA and CA 19-9 in Lung Cancer in tertiary care hospital in Eastern India

Journal Title: Journal of Medical Science And clinical Research - Year 2017, Vol 5, Issue 5

Abstract

Background: Lung cancer is the leading cause of cancer death worldwide. Unfortunately, most lung cancers are already unresectable and metastatic at initial diagnosis. Measurement of tumor markers is a noninvasive means to predict prognosis, and is therefore used in daily clinical practice. Aims & Objectives: The aim of this study was to assess the diagnostic yield of the tumour markers carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9, in serum and bronchoalveolar lavage fluid in a group of patients with bronchogenic carcinoma. Materials and Methods: Serum and bronchoalveolar lavage fluid samples were collected in a group of 38 cases with benign or malignant pulmonary diseases and 36 controls. The serum from all the subjects were analyzed for estimation of levels of various tumour markers like CEA and CA 19-9 using enzyme linked immunosorbant assay (ELISA) kits. Results: Serum CEA level was found significantly higher among lung cancer subjects with respect to controls (28.15 ± 8.11 versus 5.82 ± 2.66 µg/L; P < 0.001). Moreover, serum CA 19-9 levels were elevated in lung cancer cases as compared to controls and were statistically significant (60.08 ± 17.14 versus 23.75 ± 10.58 U/ml; P < 0.001). Serum CEA level does not have any correlation with serum CA 19-9 (r = 0.175; P=0.322) level among lung cancer subjects as well as in controls (r = 0.075; P = 0.670). Conclusion: Carcinoembryonic antigen was the most relevant marker in bronchoalveolar lavage fluid. For the factors evaluated in this study, determination of carcinoembryonic antigen and carbohydrate antigen 19- 9 in bronchoalveolar lavage fluid were clinically more useful markers in comparison with serum, although the latter may also be helpful in certain situations. Although there is no specific tumour marker for lung cancer, the combination of several can be used to diagnose most patients with lung cancer and also to rule out false positive and negative cases

Authors and Affiliations

Dr. Sanjay Kothari

Keywords

Related Articles

Health related quality of life of diabetic children and factors affecting it in Sohag University Hospital, Sohag, Egypt

Introduction: DM is the most common endocrine disease in children with increase in global incidence by 3% annually. Diabetes mellitus as chronic illness and its management negatively affect the quality of life of the dis...

Identifying people at high risk for developing sleep apnea syndrome (SAS) among obese, overweight and normal weight adults at King Fahad Medical city- Riyadh

Aim of the Study To classify people of a Saudi population into high or low risk groups for developing sleep apnea syndrome (SAS) among obese, overweight and normal weight adults.

Giant Prostatic Urethral Calculus: A Rare Case Report with Total Endoscopic Management

The giant prostatic calculus within the prostatic urethra is a rare clinical entity in the young population. Less than 20 cases have been reported in literature(1) . Most of the calculi in the urethra migrate from the bl...

An Incidental Finding of Enormous Number of Multiple Gall Stones in a Tertiary Setup in Western India

In this case report we state the occurrence of 800 gall stone found in a single patient undergoing elective cholecystectomy. The largest number of the gallstone found in a single patient is 11970.the occurrence of gallst...

Comparative Study of Efficacy of Nebulized Beta 2 Agonist vs Nebulized Adrenaline in Bronchiolitis

Bronchiolitis is an acute communicable disease predominantly manifesting in infancy mainly caused by RSV and characterized by cough, coryza, fever, grunting, tachypnoea, retractions, inspiratory crackles, expiratory whee...

Download PDF file
  • EP ID EP285547
  • DOI -
  • Views 44
  • Downloads 0

How To Cite

Dr. Sanjay Kothari (2017). Raised serum CEA and CA 19-9 in Lung Cancer in tertiary care hospital in Eastern India. Journal of Medical Science And clinical Research, 5(5), 22598-22603. https://europub.co.uk/articles/-A-285547